Two securities fraud class actions announced Sept. 30, 2026, involve Doximity, Inc. and Fractyl Health, Inc. Doximity investors may seek lead plaintiff status by Nov. 16, 2026, over alleged misstatements from Aug. 8, 2024, through May 13, 2026, concerning Newsfeed revenue growth, competition, pricing, market share and engagement tactics. Fractyl Health investors face an Oct. 20, 2026, deadline concerning alleged misstatements from Jan. 13, 2025, through Jan. 29, 2026, about Revita and the integrity of efficacy results from the REMAIN-1 Midpoint Cohort. Investors may retain counsel, take no action and remain absent class members, or seek further information.